Literature DB >> 21362045

Pro-inflammatory cytokines are raised in extrahepatic portal venous obstruction, with minimal hepatic encephalopathy.

Anshu Srivastava1, Santosh Kumar Yadav, Surender Kumar Yachha, Michael Albert Thomas, Vivek Anand Saraswat, Rakesh Kumar Gupta.   

Abstract

BACKGROUND AND AIMS: Minimal hepatic encephalopathy (MHE) and hyperammonemia are seen in patients with extrahepatic portal venous obstruction (EHPVO). Inflammation has been shown to play an important role in the pathogenesis of hepatic encephalopathy in cirrhotics. This study assessed serum pro-inflammatory cytokines and their correlation with hyperammonemia, (1)H-magnetic resonance (MR) spectroscopy-derived brain glutamine, and diffusion tensor imaging (DTI)-derived metrics in patients with EPHVO, with and without MHE.
METHODS: Neuropsychological tests, DTI, (1)H-MR spectroscopy, and estimation of blood ammonia and pro-inflammatory cytokines (tumor necrosis factor-α[TNF-α] and interleukin-6 [IL-6]) were done in 20 patients with EHPVO and eight healthy controls.
RESULTS: Pro-inflammatory cytokines (TNF-α and IL-6), blood ammonia, brain glutamine, and mean diffusivity were increased in both patient groups, as compared to controls. Patients with MHE (n-12) had significantly higher TNF-α, IL-6, blood ammonia, brain glutamine, and mean diffusivity, signifying brain edema, than controls. A significant, positive correlation was seen between TNF-α and IL-6 and between blood ammonia and TNF-α, IL-6, and brain glutamine. Significant, positive correlations of TNF-α, IL-6, and blood ammonia with mean diffusivity values were seen in various brain regions, including spectroscopy voxel-derived mean diffusivity.
CONCLUSION: Patients with extrahepatic portal vein obstruction have inflammation and hyperammonemia made evident by higher blood TNF-α, IL-6, ammonia, and brain glutamine levels. A significant correlation between hyperammonemia, pro-inflammatory cytokines, and cerebral edema on DTI in various brain regions suggests that both these factors play a role in the pathogenesis of MHE in these patients.
© 2011 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21362045     DOI: 10.1111/j.1440-1746.2011.06706.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  7 in total

1.  Hippocampal atrophy and functional connectivity disruption in cirrhotic patients with minimal hepatic encephalopathy.

Authors:  Weiwen Lin; Xuhui Chen; Yong-Qing Gao; Zhe-Ting Yang; Weizhu Yang; Hua-Jun Chen
Journal:  Metab Brain Dis       Date:  2019-07-30       Impact factor: 3.584

Review 2.  Idiopathic portal hypertension and extrahepatic portal venous obstruction.

Authors:  Rajeev Khanna; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2018-02-20       Impact factor: 6.047

3.  Hepatic Encephalopathy in Children With Acute Liver Failure: Utility of Serum Neuromarkers.

Authors:  Nicole A Toney; Michael J Bell; Steven H Belle; Regina M Hardison; Norberto Rodriguez-Baez; Kathleen M Loomes; Yoram Vodovotz; Ruben Zamora; Robert H Squires
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-07       Impact factor: 2.839

Review 4.  Cognition-tracking-based strategies for diagnosis and treatment of minimal hepatic encephalopathy.

Authors:  Weijia Han; Huanqian Zhang; Ying Han; Zhongping Duan
Journal:  Metab Brain Dis       Date:  2020-06-03       Impact factor: 3.584

Review 5.  Cognitive Impairement in Non-Cirrhotic Portal Hypertension: Highlights on Physiopathology, Diagnosis and Management.

Authors:  Stefania Gioia; Silvia Nardelli; Oliviero Riggio; Jessica Faccioli; Lorenzo Ridola
Journal:  J Clin Med       Date:  2021-12-25       Impact factor: 4.241

6.  Polyherbal formulation Anoac‑H suppresses the expression of RANTES and VEGF for the management of bleeding hemorrhoids and fistula.

Authors:  Ashwin Porwal; Gopal C Kundu; Gajanan Bhagwat; Ramesh Butti
Journal:  Mol Med Rep       Date:  2021-08-20       Impact factor: 2.952

7.  Pathogenesis of hepatic encephalopathy.

Authors:  Irena Ciećko-Michalska; Małgorzata Szczepanek; Agnieszka Słowik; Tomasz Mach
Journal:  Gastroenterol Res Pract       Date:  2012-12-17       Impact factor: 2.260

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.